Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Gemelli - IRCCS, Università Cattolica del Sacro Cuore, Largo F. Vito 1, Roma, Italy.
Barbra Streisand Women's Heart Center, Smidt Cedars-Sinai Heart Institute, Cedars-Sinai Medical Center, 127 San Vicente Blvd, Los Angeles, CA, USA.
Eur Heart J. 2019 Aug 1;40(29):2455-2462. doi: 10.1093/eurheartj/ehy857.
Persistence or recurrence of angina after a percutaneous coronary intervention (PCI) may affect about 20-40% of patients during short-medium-term follow-up. This appears to be true even when PCI is 'optimized' using physiology-guided approaches and drug-eluting stents. Importantly, persistent or recurrent angina post-PCI is associated with a significant economic burden. Healthcare costs may be almost two-fold higher among patients with persistent or recurrent angina post-PCI vs. those who become symptom-free. However, practice guideline recommendations regarding the management of patients with angina post-PCI are unclear. Gaps in evidence into the mechanisms of post-PCI angina are relevant, and more research seems warranted. The purpose of this document is to review potential mechanisms for the persistence or recurrence of angina post-PCI, propose a practical diagnostic algorithm, and summarize current knowledge gaps.
经皮冠状动脉介入治疗(PCI)后心绞痛的持续或复发可能会在短期至中期随访期间影响约 20-40%的患者。即使使用生理学指导方法和药物洗脱支架对 PCI 进行“优化”,这种情况似乎也是如此。重要的是,PCI 后持续或复发的心绞痛与显著的经济负担有关。与 PCI 后症状消失的患者相比,PCI 后持续或复发心绞痛的患者的医疗保健费用可能几乎高出一倍。然而,关于 PCI 后心绞痛患者管理的实践指南建议尚不清楚。PCI 后心绞痛的机制方面存在证据空白,似乎需要更多的研究。本文旨在回顾 PCI 后心绞痛持续或复发的潜在机制,提出实用的诊断算法,并总结当前的知识空白。